Skip to main content
Contact Us
Subscribe
E-Edition
82°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Archives
Best of 2025
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
AtriCure, Inc. - Common Stock
(NQ:
ATRC
)
31.98
+0.59 (+1.88%)
Streaming Delayed Price
Updated: 11:44 AM EDT, Jul 3, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about AtriCure, Inc. - Common Stock
< Previous
1
2
3
4
5
6
Next >
AtriCure to Participate in the 42nd Annual J.P. Morgan Healthcare Conference
December 20, 2023
From
AtriCure
Via
Business Wire
Where AtriCure Stands With Analysts
November 29, 2023
Via
Benzinga
AtriCure to Participate in the Piper Sandler 35th Annual Healthcare Conference
November 15, 2023
From
AtriCure, Inc.
Via
Business Wire
AtriCure Releases 2023 ESG Report
November 14, 2023
From
AtriCure, Inc.
Via
Business Wire
What 7 Analyst Ratings Have To Say About AtriCure
May 03, 2023
Via
Benzinga
Analyst Ratings for AtriCure
February 22, 2023
Via
Benzinga
AtriCure Reports Third Quarter 2023 Financial Results
November 01, 2023
From
AtriCure, Inc.
Via
Business Wire
AtriCure to Participate in the Stifel 2023 Healthcare Conference
October 31, 2023
From
AtriCure, Inc.
Via
Business Wire
AtriCure to Announce Third Quarter 2023 Financial Results
October 11, 2023
From
AtriCure, Inc.
Via
Business Wire
Earnings Outlook For AtriCure
February 20, 2023
Via
Benzinga
AtriCure Reports Second Quarter 2023 Financial Results
July 25, 2023
From
AtriCure, Inc.
Via
Business Wire
AtriCure to Participate at Upcoming Investor Conferences
July 21, 2023
From
AtriCure, Inc.
Via
Business Wire
AtriCure to Announce Second Quarter 2023 Financial Results
July 03, 2023
From
AtriCure, Inc.
Via
Business Wire
New Data Out Of Cleveland Clinic Shows BioSig PURE EP May Be Used For More Precise Approach For $6 Billion Annual Atrial Fibrillation Market
May 24, 2023
Cleveland Clinic researchers presented data from three new studies involving BioSig Technologies’ (NASDAQ: BSGM) proprietary PURE EP Platform at the annual Heart Rhythm 2023 meeting in Ne
Via
Benzinga
AtriCure Reports First Quarter 2023 Financial Results
May 02, 2023
From
AtriCure, Inc.
Via
Business Wire
AtriCure to Participate in the 2023 Bank of America Health Care Conference and Host a Cryo Nerve Block Therapy Investor Education Webcast
April 19, 2023
From
AtriCure, Inc.
Via
Business Wire
AtriCure to Announce First Quarter 2023 Financial Results
April 11, 2023
From
AtriCure, Inc.
Via
Business Wire
AtriCure to Participate in the 22nd Annual Needham Virtual Healthcare Conference
April 03, 2023
From
AtriCure, Inc.
Via
Business Wire
AtriCure Reports Fourth Quarter 2022 and Full Year 2022 Financial Results
February 21, 2023
From
AtriCure, Inc.
Via
Business Wire
AtriCure to Participate in the Oppenheimer 33rd Annual Healthcare Conference
February 17, 2023
From
AtriCure, Inc.
Via
Business Wire
AtriCure Announces the First Patient Treated in the LeAAPS™ Clinical Trial
January 31, 2023
From
AtriCure, Inc.
Via
Business Wire
AtriCure to Announce Fourth Quarter and Full Year 2022 Financial Results and Participate in 2023 BTIG Medical Technology Conference
January 24, 2023
From
AtriCure, Inc.
Via
Business Wire
AtriCure Reports Preliminary Results for Fourth Quarter and Full Year 2022, Provides Financial Outlook for 2023
January 09, 2023
From
AtriCure, Inc.
Via
Business Wire
AtriCure to Participate in the 41st Annual J.P. Morgan Healthcare Conference
December 20, 2022
From
AtriCure, Inc.
Via
Business Wire
Moderna To Rally Over 42%? Here Are 10 Other Price Target Changes For Monday
December 19, 2022
Morgan Stanley cut VTEX (NYSE: VTEX) price target from $7 to $5. Morgan Stanley analyst Cesar Medina downgraded the stock from Overweight to Equal-Weight. VTEX shares fell 4.9% to close at $3.52 on...
Via
Benzinga
AtriCure Wins 2022 NACD Diversity, Equity, & Inclusion Award
December 08, 2022
From
AtriCure, Inc.
Via
Business Wire
AtriCure to Present at 34th Annual Piper Sandler Healthcare Conference
November 08, 2022
From
AtriCure, Inc.
Via
Business Wire
AtriCure Reports Third Quarter 2022 Financial Results
November 01, 2022
From
AtriCure, Inc.
Via
Business Wire
AtriCure to Participate in Upcoming Investor Conferences
October 25, 2022
From
AtriCure, Inc.
Via
Business Wire
AtriCure to Announce Third Quarter 2022 Financial Results
October 11, 2022
From
AtriCure, Inc.
Via
Business Wire
< Previous
1
2
3
4
5
6
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.
